First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis

NCT07527923 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer
Atopic Dermatitis

Interventions

DRUG: REGN20423
OTHER: Placebo

Sponsor

Regeneron Pharmaceuticals